A Race to the Starting Line
Richard Weinshilboum, MD

Pharmacogenomics 101: An Introduction to Foundational Concepts
Christopher B. Grilli, PharmD, MBA, BCACP

Pharmacogenomics' Emerging Role
Richard Weinshilboum, MD

Pharmacogenomics From a Patient Perspective: GINA and Other Important Questions
Teresa M. Kruisselbrink, MS, CGC, LCGC

Legal Implications of PGx Testing
Sharon C. Zehe, JD

Pharmacogenomics from the Patient Perspective: Panel Discussion
Darryl Chutka, MD; Matthew Ferber, PhD; Karen Meagher, PhD; Sharon Zehe, JD

Clinical Laboratory Testing in PGx: "The Lab" 101
Ann M. Moyer, MD, PhD

Pharmacogenomics Testing: Role in Clinical Medicine
Denise M. Dupras, MD, PhD

Pharmacogenomics of Analgesics
Wayne T. Nicholson, MD, PharmD

Pharmacogenomics of Antidepressants
Adrijana Kekic, PharmD, BCACP

Using Pharmacogenomics to Predict Drug Hypersensitivity
John Zeuli, PharmD, BCPS AQ-ID

Gout Management: Role of Pharmacogenomics
Denise M. Dupras, MD, PhD

HLA and Hypersensitivity - Carbamazepine
Jyothsna Giri, MD, MBA

Pharmacogenomics in Cardiovascular Disease
Naveen Pereira, MD

Warfarin & Statin Pharmacogenomics Cases
Jan Anderson, PharmD, BCPS, BCACP

Polypharmacy and PGx: Multi-drug, Herbal/Dietary Supplement Case Study
Michael J. Schuh, PharmD, RPH

PGx Use in Patients with Gastro Esophageal Reflux Disease
Imad Absah, MD

10 Considerations for the Clinician Applying Pharmacogenomics to Practice
W.T. Nicholson, MD, PharmD, MSC, DABCP, BCPS

Pharmacogenomics at the Clinic: Panel Discussion
Darryl Chutka, MD; Paul Takahashi, MD; Jennifer Bold, APRN, CNP, DNP; Matthew Bernard, MD

Utilizing Pharmacogenomics Guidelines and Other Resources
Jessica Wright, PharmD, BCACP

Significant PGx Cases
Heather Randles, PharmD

Pharmacogenomics: Case Review - From My Practice to Yours
Sheena K. Crosby, PharmD, RPH